• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
ENvue Medical, Inc. - Common Stock
Pasqal Holding SA - Ordinary Shares
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Wave Life Sciences, Inc. - Common Stock (NQ:WVE)

3.170 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,197
Open 3.170
Bid (Size) 3.130 (1,000)
Ask (Size) 3.250 (600)
Prev. Close 3.170
Today's Range 3.170 - 3.170
52wk Range 3.040 - 21.73
Shares Outstanding 98,983,261
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026
Today 8:30 EDT
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
October 19, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire

Performance

52-Week Range 85.4% below 52-week high
3.170
3.0452W Low 21.7352W High
1 Week 3.4% below 1-week high
3.041W Low 3.281W High

Wave Life Sciences, Inc. - Common Stock (WVE) traded between $3.04 and $21.73 over the past 52 weeks and last traded at $3.17, 85.4% below its 52-week high. Over the past week it ranged between $3.04 and $3.28.

Past 12 Months
+1.0%
-25.5%
-44.7%
-58.2%
-80.1%
-59.4%
1W +$0.03
1M -$1.08
3M -$2.56
6M -$4.41
YTD -$12.78
1Y -$4.64

WVE was -59.4% over the past year, -58.2% over six months, -80.1% year to date, +1.0% in the last week.

12 Months vs Market
WVE
-59.4%
DIA
+11.1%
SPY
+14.2%
QQQ
+17.5%
IWM
+9.3%

Over the past 12 months WVE returned -59.4% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 0.00× 3-mo avg
Today 2,197 3-mo avg 3.2M
1W
3.1M
1M
3.2M
3M
3.2M
6M
3.4M
YTD
3.7M
1Y
4.5M

WVE most recently traded 2,197 shares against a 3-month average daily volume of 3.2M.

More News

Read More
News headline image
Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference
October 13, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
October 01, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences (NASDAQ:WVE) Plunges After Q2 Revenue Miss ↗
July 30, 2026
Via Chartmill
News headline image
Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development
September 30, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity
September 23, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer
September 22, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference
September 03, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Announces Completion of Redomiciliation to Delaware
August 10, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware
August 05, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences to Present at Upcoming Investor Conferences
August 04, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript ↗
August 03, 2026
Via The Motley Fool
Topics Earnings
News headline image
Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript ↗
July 30, 2026
Via The Motley Fool
Topics Earnings
News headline image
WAVE Life Sciences Q2 Earnings Call Highlights ↗
July 30, 2026
Via MarketBeat
Topics Earnings
News headline image
Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
July 30, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
July 23, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation
July 07, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
June 24, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences to Present at Upcoming Investor Conferences
June 01, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter ↗
May 31, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May 18, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave (WVE) Q1 2026 Earnings Call Transcript ↗
April 29, 2026
Via The Motley Fool
Topics Earnings
News headline image
Wave (WVE) Q2 2025 Earnings Call Transcript ↗
April 28, 2026
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Wave Life Sciences, Inc. - Common Stock publicly traded?
Yes, Wave Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does Wave Life Sciences, Inc. - Common Stock trade on?
Wave Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Wave Life Sciences, Inc. - Common Stock?
The ticker symbol for Wave Life Sciences, Inc. - Common Stock is WVE on the Nasdaq Stock Market
What is the current price of Wave Life Sciences, Inc. - Common Stock?
The current price of Wave Life Sciences, Inc. - Common Stock is 3.170
When was Wave Life Sciences, Inc. - Common Stock last traded?
The last trade of Wave Life Sciences, Inc. - Common Stock was at 10/19/26 04:00 PM ET
What is the market capitalization of Wave Life Sciences, Inc. - Common Stock?
The market capitalization of Wave Life Sciences, Inc. - Common Stock is 313.78M
How many shares of Wave Life Sciences, Inc. - Common Stock are outstanding?
Wave Life Sciences, Inc. - Common Stock has 314M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap